Actively Recruiting
Urethral Resistive Index (URI): A New Parameter for Diagnosing Urethral Obstruction
Led by Ankara City Hospital Bilkent · Updated on 2026-04-06
60
Participants Needed
1
Research Sites
21 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This prospective observational study aims to evaluate the diagnostic accuracy of a new, non-invasive uroflowmetry parameter called the Urethral Resistive Index (URI) for detecting urethral stricture in men. Currently, diagnosing urethral stricture often requires invasive procedures like surgery or pressure-flow studies. This research seeks to develop URI as a practical and painless screening tool that could reduce the need for such invasive interventions. Study Procedures: A total of 60 male participants (30 with suspected urethral stricture and 30 healthy volunteers) will be enrolled. Participants will undergo two standard, non-invasive uroflowmetry (voiding) tests. The first test is a routine natural voiding session. The second test involves a "forced voiding" (Valsalva maneuver) once the participant feels a sufficient urge to urinate again. The URI is then calculated by comparing the flow rates of these two sessions. Goals and Benefits: The primary goal is to determine the optimal "cut-off" value of the URI that accurately identifies a surgically proven urethral stricture. By demonstrating URI's effectiveness, the study aims to expedite the diagnostic process and spare patients from unnecessary invasive tests. The procedure involves minimal risk, primarily temporary discomfort or psychological stress during the voiding tests
CONDITIONS
Official Title
Urethral Resistive Index (URI): A New Parameter for Diagnosing Urethral Obstruction
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male participants aged between 18 and 80 years
- Patients scheduled for surgery due to suspected urethral stricture with diagnosis confirmed during surgery
- Healthy male volunteers without lower urinary tract symptoms
- Signed informed consent form
You will not qualify if you...
- Voiding volume less than 150 mL
- Obstruction caused by conditions other than stricture, such as Benign Prostatic Hyperplasia (BPH)
- Diagnosis of neurogenic bladder dysfunction or history of neurological disease affecting bladder function
- Presence of severe comorbidities
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Ankara Bilkent City Hospital
Ankara, Universiteler, Turkey (Türkiye), 06800
Actively Recruiting
Research Team
Y
Yusuf Gökkurt
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here